# Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

> **NCT02434562** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 73 (actual)

## Conditions studied

- Hypogonadism
- Estrogens
- Testosterone
- Androgens

## Interventions

- **OTHER:** Serum (with or without urine) samples

## Key facts

- **NCT ID:** NCT02434562
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-09-30
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434562, "Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02434562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*